♪ PODCAST: Coupling AI with Biology in Early Drug Discovery with Rangaprasad Sarangarajan @ Berg Health
By NextLevel Life Sciences - March 12, 2019

Podcast with Rangaprasad Sarangarajan, Senior Vice President and CSO of Berg Health. Rangaprasad explains what the "Interrogative Biology" platform developed by Berg Health is, and how it enables early drug discovery processes from target identification to molecular profiling for patient stratification and clinical development. Enjoy!